Paxman Ab Stock Performance
| PXMBF Stock | USD 3.50 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Paxman AB are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Paxman AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Paxman AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.6 M | |
| Total Cashflows From Investing Activities | -24.4 M |
Paxman |
Paxman AB Relative Risk vs. Return Landscape
If you would invest 350.00 in Paxman AB on September 28, 2025 and sell it today you would earn a total of 0.00 from holding Paxman AB or generate 0.0% return on investment over 90 days. Paxman AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Paxman, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Paxman AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Paxman AB's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Paxman AB, and traders can use it to determine the average amount a Paxman AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PXMBF |
Based on monthly moving average Paxman AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Paxman AB by adding Paxman AB to a well-diversified portfolio.
Paxman AB Fundamentals Growth
Paxman Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Paxman AB, and Paxman AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Paxman Pink Sheet performance.
| Return On Equity | -0.0254 | |||
| Return On Asset | -0.0412 | |||
| Profit Margin | (0.02) % | |||
| Current Valuation | 76.35 M | |||
| Shares Outstanding | 19.01 M | |||
| Price To Book | 22.79 X | |||
| Price To Sales | 13.45 X | |||
| Revenue | 96.2 M | |||
| EBITDA | 2.9 M | |||
| Total Debt | 5.83 M | |||
| Debt To Equity | 0.14 % | |||
| Cash Flow From Operations | (4.14 M) | |||
| Total Asset | 166.34 M | |||
About Paxman AB Performance
By analyzing Paxman AB's fundamental ratios, stakeholders can gain valuable insights into Paxman AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Paxman AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Paxman AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Paxman AB , together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. The company was founded in 1996 and is based in Karlshamn, Sweden. Paxman Ab is traded on OTC Exchange in the United States.Things to note about Paxman AB performance evaluation
Checking the ongoing alerts about Paxman AB for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Paxman AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Paxman AB generated a negative expected return over the last 90 days | |
| The company reported the revenue of 96.2 M. Net Loss for the year was (12.78 M) with profit before overhead, payroll, taxes, and interest of 64.52 M. | |
| Paxman AB generates negative cash flow from operations | |
| About 64.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Paxman AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Paxman AB's stock is overvalued or undervalued compared to its peers.
- Examining Paxman AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Paxman AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Paxman AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Paxman AB's pink sheet. These opinions can provide insight into Paxman AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Paxman Pink Sheet analysis
When running Paxman AB's price analysis, check to measure Paxman AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paxman AB is operating at the current time. Most of Paxman AB's value examination focuses on studying past and present price action to predict the probability of Paxman AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paxman AB's price. Additionally, you may evaluate how the addition of Paxman AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |